Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

NDAQ:NVCN - Post by User

Neovasc Inc. > The split is on the table

<< Previous

Bullboard Posts

Next >>

Comment by Montrose9on May 23, 2018 3:34pm

62 Views

Post# 28071380

RE:RE:RE:RE:RE:RE:RE:RE:RE:The split is on the table

Pretty straight forward if you bought 100 shares at 2 dollars and you end up with 1 share that share cost you 200 dollars plus the brokerage. Of course if they do not alter the share structure and the shares go back to 2 dollars then those who buy now are golden. I will be the first to admit I dont enough about this listing to declare it has no value

<< Previous

Bullboard Posts

Next >>

Mullen Group: Navigates market challenges towards success